Reassessing the Role of Anthracyclines in Early HER2-Positive Breast Cancer in the Era of HER2-Targeted Therapy and Treatment De-Escalation: A Systematic Review and Narrative Synthesis
- DOI
- 10.3390/jcm15187303
- Published
- 2026-09-20
- Container
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/jcm15187303,
title = {Reassessing the Role of Anthracyclines in Early HER2-Positive Breast Cancer in the Era of HER2-Targeted Therapy and Treatment De-Escalation: A Systematic Review and Narrative Synthesis},
author = {Zhuldyz Myrzabay and Nazym Askambayeva and Ahmad J. Harahsheh and Reezal Ishak and Mohamad Aljofan},
year = {2026},
journal = {Journal of Clinical Medicine},
doi = {10.3390/jcm15187303},
url = {https://doi.org/10.3390/jcm15187303}
}RIS
TY - JOUR TI - Reassessing the Role of Anthracyclines in Early HER2-Positive Breast Cancer in the Era of HER2-Targeted Therapy and Treatment De-Escalation: A Systematic Review and Narrative Synthesis AU - Zhuldyz Myrzabay AU - Nazym Askambayeva AU - Ahmad J. Harahsheh AU - Reezal Ishak AU - Mohamad Aljofan PY - 2026 JO - Journal of Clinical Medicine DO - 10.3390/jcm15187303 UR - https://doi.org/10.3390/jcm15187303 ER -
APA
Myrzabay, Z., Askambayeva, N., Harahsheh, A. J., Ishak, R., & Aljofan, M. (2026). Reassessing the Role of Anthracyclines in Early HER2-Positive Breast Cancer in the Era of HER2-Targeted Therapy and Treatment De-Escalation: A Systematic Review and Narrative Synthesis. Journal of Clinical Medicine. https://doi.org/10.3390/jcm15187303
Source records
- crossref · retrieved 2026-09-26T15:12:14.575Z